Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea

BACKGROUND: Next-generation sequencing (NGS) is an approved test to select patients for BRAF V600E targeted therapy in Korea. However, the high cost, long turnaround times, and the need for sophisticated equipment and skilled personnel limit the use of NGS in daily practice. Immunohistochemistry (IH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sunhee, Choi, Yoon-La, Shim, Hyo Sup, Lee, Geon Kook, Ha, Seung Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682223/
https://www.ncbi.nlm.nih.gov/pubmed/36288742
http://dx.doi.org/10.4132/jptm.2022.08.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682223/
https://www.ncbi.nlm.nih.gov/pubmed/36288742
http://dx.doi.org/10.4132/jptm.2022.08.22

Ejemplares similares